0.0(top 100%)
impact factor
48(top 100%)
papers
32(top 100%)
citations
3(top 100%)
h-index
0.0(top 100%)
extended IF
51
all documents
40
doc citations
4(top 100%)
g-index
Top Authors (by articles)
# | Author | Articles | Citations | R ARank | R CRank |
---|---|---|---|---|---|
1 | Jeffrey Cummings | 3 | 0 | 21 | 95 |
2 | Jeremy M Shefner | 1 | 0 | 12 | 26 |
2 | Srihari Gopal | 1 | 0 | 15 | 36 |
2 | Michael F Green | 1 | 3 | 25 | 56 |
2 | Lisa A Marsch | 1 | 0 | 30 | 87 |
2 | Barbara J Sahakian | 1 | 0 | 79 | 208 |
2 | Mauricio Tohen | 1 | 0 | 16 | 38 |
2 | Filip Van Nieuwerburgh | 1 | 0 | 38 | 166 |
2 | Michel D Ferrari | 1 | 0 | 37 | 99 |
2 | Vikas Yadav | 1 | 0 | 2 | 15 |
2 | Dieter Deforce | 1 | 0 | 78 | 339 |
2 | Evdokia Anagnostou | 1 | 2 | 22 | 58 |
2 | Sven E Pålhagen | 1 | 0 | 1 | 4 |
2 | James C Grotta | 1 | 1 | 31 | 91 |
2 | Jair J Mari | 1 | 0 | 46 | 137 |
2 | Roger Stupp | 1 | 2 | 18 | 39 |
2 | Kimford J Meador | 1 | 0 | 32 | 74 |
2 | Robert H Dworkin | 1 | 1 | 9 | 27 |
2 | Kelly C Allison | 1 | 0 | 21 | 55 |
2 | Sheng Zhang | 1 | 0 | 1 | 9 |
2 | Stephen R Marder | 1 | 3 | 14 | 28 |
2 | Joachim Yahalom | 1 | 0 | 18 | 50 |
2 | Sara Rodríguez-mora | 1 | 2 | 5 | 23 |
2 | Peter Hedera | 1 | 1 | 25 | 69 |
2 | Zarife Sahenk | 1 | 7 | 15 | 34 |
2 | Shomik Sengupta | 1 | 2 | 17 | 52 |
2 | Eric Hollander | 1 | 2 | 25 | 47 |
2 | Paul B Fitzgerald | 1 | 1 | 73 | 134 |
2 | Herbert Y Meltzer | 1 | 0 | 32 | 68 |
2 | Tobey J Macdonald | 1 | 0 | 17 | 49 |
2 | Kamyar Keramatian | 1 | 1 | 6 | 17 |
2 | Kelly E Lyons | 1 | 0 | 6 | 36 |
2 | Davide Lombardi | 1 | 0 | 3 | 14 |
2 | Rajesh Pahwa | 1 | 0 | 19 | 53 |
How influential is Progress in Neurotherapeutics and Neuropsychopharmacology in terms of citations?
Based on the citation analysis of 49 articles Progress in Neurotherapeutics and Neuropsychopharmacology has published so far, 61% of its articles have received no citation at all. 9 articles (about 18% of the total articles) have received only one citation. 18.37% of the articles (0) have received over 100 citations.